Thursday, September 13th. |
|
• Opening Remarks. |
|
9:00
AM - 9:15 AM.
|
Carlos
Arteaga, Román Pérez Soler.
|
• New
Anticancer Therapies.
|
|
| Chairpersons: Omar Coso, Patricia Elizalde. | |
|
9:15
AM - 9:45 AM.
|
Promising
Agents in Early Clinical Trials. Alex A. Adjei, Buffalo, New York, USA. |
|
9:45
AM - 10:15 AM.
|
Overview
of New Drug Development at the NCI. John Wright, Bethesda, USA. |
10:15
AM - 10:35 AM.
|
Round Table and Questions with Speakers and Chairpersons. |
10:35
AM - 10:50 AM.
|
Coffee Break. |
• Breast
Cancer.
|
|
| Chairpersons: Edith Kordon , Elizabeth Mickiewicz. | |
|
10:50
AM - 11:20 AM.
|
Antiestrogens
in Breast Cancer. Mechanisms of Resistance and Interaction with Anti- ErbB Therapies. Carlos L. Arteaga, Nashville, USA. |
11:20
AM - 11:50 PM.
|
Bevacizumab
in Breast Cancer. Hernán Cortés Funes, Madrid, Spain. |
11:50
PM - 12:20 PM.
|
New
Drugs in Breast Cancer. Javier Cortés Castán, Barcelona, Spain. |
|
12:20
PM - 12:40 PM.
|
Round Table and Questions with Speakers and Chairpersons. |
|
1:10
PM - 2:40 PM.
|
GSK Satellite Symposia. |
2:40
PM - 3:00 PM |
Coffee Break. |
• GI
and colorectal Cancer.
|
|
| Chairpersons: Gonzalo Recondo, Enrique Roca | |
3:00
PM - 3:30 PM.
|
Anti-VEGF
for Colon Cancer, Updates and New Issues. Herbert Hurwitz, Durham, USA. |
3:30
PM - 4:00 PM.
|
Targeted
Therapies in the Treatment of Gastrointestinal Cancer, The Clinical Perspective. Josep Tabernero, Barcelona, Spain. |
4:00
PM - 4:20 PM.
|
Round Table and Questions with Speakers and Chairpersons. |
|
4:20
PM - 4:45 PM.
|
Coffee Break sponsored by Merck. |
4:45
PM - 6:15 PM.
|
Merck
Satellite Symposia. “Erbitux: Potential for cure, |
6:15
PM – 6:55 PM.
|
Cocktail sponsored by Merck. |
| Adjourn for the day. | |
Friday,
September 14th.
|
|
• Opening
Remarks.
|
|
9:00
AM – 9:15 AM.
|
Román Pérez Soler. |
• Lung
Cancer.
|
|
| Chairpersons: Gonzalo Recondo, Eduardo Richardet, Maximilano Van Kooten. | |
|
9:15
AM – 9 :45 AM.
|
New
Therapies for Lung Cancer. Román Pérez Soler, New York, USA. |
9:45
AM – 10:15 AM.
|
Acquired
Resistance to EGFR Inhibitors in Lung Cancer. William Pao, New York, USA. |
|
10:15
AM – 10:45 AM.
|
Customized
Treatment for Lung Cancer. Rafael Rosell, Barcelona Spain. |
10:45
AM – 11:15 AM.
|
Current
Options of Second-Line Therapy in Lung Cancer. Alex A. Adjei, Buffalo, New York, USA. |
11:15
AM – 11:35 AM.
|
Round Table and Questions with Speakers and Chairpersons. |
11:35
AM – 11:50 AM.
|
Coffee Break. |
• Hematological
Malignancies.
|
|
| Chairpersons: Claudia Corrado, Renata Pasqualini, Julio Sánchez Avalos. | |
11:50
AM – 12:20 PM.
|
Leukemias,
Novel Treatments and Targets. Farhad Ravandi, Houston, USA. |
12:20
PM – 12:50 PM.
|
Oncogenomics to Target Multiple Myeloma Cells in the Bone Marrow Microenvironment. Sagar Lonial, Atlanta, USA. |
12:50
PM – 1:20 PM.
|
Epigenetic
Therapy, Future treatments of MDS. Carlos M. De Castro, Durham, USA. |
1:20
PM – 1:40 PM.
|
Round Table and Questions with Speaker and Chairperson. |
2:00
PM – 3:30 PM.
|
Janssen
Satellite Symposia. "New therapeutic options in Lymphoprolipheratives Syndromes", NFkB and D1 Cyclin as therapeutic targets. |
3:30
PM – 3:45 PM.
|
Coffee Break. |
• Other
Malignancies.
|
|
| Chairpersons: Enrique Díaz Cantón, Pedro Politi. | |
3:45
PM – 4:15 PM.
|
New
Approaches for Renal Cancer. Janice Dutcher, New York, USA. |
4:15
PM – 4:45 PM.
|
Advances
in Chemoprevention for Lung and Head and Neck Cancer. Scott Lippman, Houston, USA. |
4:45
PM – 5:05 PM.
|
Round Table and Questions with Speakers and Chairpersons. |
• Immunotherapy.
|
|
| Chairpersons: Graciela Fernández Alonso, Dr. Norberto Zwirner. | |
5:05
PM – 5:35 PM.
|
Impact
of Protein-Glycan Interactions in Cancer Immunoediting. Gabriel Rabinovich, Buenos Aires, Argentina. |
5:35
PM – 6:05 PM.
|
New
Developments in Immunotherapy of Cancer. Nora Disis, Seattle, Washington, USA. |
6:05
PM – 6:25 PM.
|
Round Table and Questions with Speakers and Chairpersons. |
6:25
PM – 6:35 PM.
|
Closing Remarks. Román Pérez Soler. |
